Clinical Scorecard: Assessment of Initial Psychotic Symptoms in Pediatric Patients: A Retrospective Study
At a Glance
Category
Detail
Condition
Psychotic symptoms in children and adolescents including primary psychiatric and secondary medical causes
Key Mechanisms
Psychosis may arise from primary psychiatric disorders (e.g., schizophrenia, bipolar disorder) or secondary etiologies such as substance-induced or medical conditions (neurologic, autoimmune, infectious, metabolic)
Target Population
Children and adolescents (ages 3.1–17.9 years) presenting with first episode psychotic symptoms
Care Setting
Tertiary pediatric referral center
Key Highlights
Approximately 23.5% of pediatric patients with first-episode psychosis had substance-/medication-induced or medically-associated psychosis.
Younger age, very early onset psychosis (<13 years), and catatonia at presentation were more common in secondary psychosis cases.
Most routine investigations did not identify secondary causes, highlighting the importance of targeted evaluation based on clinical suspicion.
Guideline-Based Recommendations
Diagnosis
Comprehensive assessment including history, physical exam, and clinician-directed laboratory tests for infectious, neurologic, autoimmune, or metabolic causes.
Use of neuroimaging and EEG as clinically indicated.
Differential diagnosis to exclude secondary medical causes per DSM-5 requirements.
Management
Baseline laboratory testing (CBC, liver and renal function, metabolic parameters, thyroid function) at first diagnosis.
More extensive evaluation reserved for atypical presentations (e.g., cognitive/motor deterioration, focal neurologic signs, delirium).
Monitoring & Follow-up
Follow-up assessments up to 12 months to confirm diagnostic stability.
Multidisciplinary case conferences to review and confirm diagnoses.
Risks
Failure to identify secondary medical causes may lead to inappropriate treatment.
Secondary psychoses require different management strategies than primary psychiatric disorders.
Patient & Prescribing Data
Children and adolescents hospitalized with first presentation of psychotic symptoms
Baseline evaluations prior to antipsychotic treatment are recommended; targeted investigations guide appropriate management especially in suspected secondary psychosis.
Clinical Best Practices
Perform clinician-directed, targeted medical evaluations rather than routine extensive testing in all cases.
Consider younger age, early onset, and catatonia as clinical flags for secondary etiologies.
Use multidisciplinary team approach for diagnosis confirmation and management planning.
Ensure thorough documentation of prior subthreshold symptoms to aid differentiation between primary and secondary psychosis.
Genetically predicted urinary metabolite levels were associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa in a Mendelian randomization analysis.
